Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada.

Ogilvie GS, Cook DA, Taylor DL, Rank C, Kan L, Yu A, Mei W, van Niekerk DJ, Coldman AJ, Krajden M.

Vaccine. 2013 Feb 4;31(7):1129-33. doi: 10.1016/j.vaccine.2012.09.085. Epub 2012 Dec 25.

PMID:
23273510
[PubMed - indexed for MEDLINE]
2.

Prevalence of human papillomavirus in women attending cervical screening in the UK and Ireland: new data from northern Ireland and a systematic review and meta-analysis.

Anderson L, O'Rorke M, Jamison J, Wilson R, Gavin A; HPV Working Group members.

J Med Virol. 2013 Feb;85(2):295-308. doi: 10.1002/jmv.23459. Epub 2012 Nov 14. Review.

PMID:
23161367
[PubMed - indexed for MEDLINE]
3.

Canadian oncogenic human papillomavirus cervical infection prevalence: systematic review and meta-analysis.

Tricco AC, Ng CH, Gilca V, Anonychuk A, Pham B, Berliner S.

BMC Infect Dis. 2011 Sep 5;11:235. doi: 10.1186/1471-2334-11-235. Review.

PMID:
21892939
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Detection and genotyping of cervical HPV with simultaneous cervical cytology in Turkish women: a hospital-based study.

Yuce K, Pinar A, Salman MC, Alp A, Sayal B, Dogan S, Hascelik G.

Arch Gynecol Obstet. 2012 Jul;286(1):203-8. doi: 10.1007/s00404-012-2280-z. Epub 2012 Mar 7. Review.

PMID:
22395863
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk